A CASE OF NONSMALL-CELL LUNG CANCER WITH ANAPHYLAXIS AFTER 41 COURSES OF PEMBROLIZUMAB ALONG WITH ADRENAL INSUFFICIENCY AS AN IMMUNE-RELATED ADVERSE EVENT



Account has been disabled due to a violation of Terms of Service.

Contact Moderators